Immorta Bio is developing autologous stem cell and immunotherapy solutions to combat aging and enhance cellular regeneration. Aging is the … Continue reading "Harnessing the power of personalized cell therapy"...
Progress in spinal cord injury lays the foundation for regenerative therapies that ‘target aging and chronic disease at a cellular … Continue reading "Cellino’s regenerative medicine tie-up with Matricelf is...
New COO Michael Ringel says company is confident as it prepares for clinical studies in glaucoma and NAION later this … Continue reading "Life Bio ready for world’s first partial...
Regenerative medicine startup aims to regenerate damaged tissues, modulate chronic inflammation and extend functional healthspan. Longevity biotech ReParris has launched … Continue reading "ReParris emerges to redefine aging as a...
Biotech gains DSMB approval to escalate dosing as it advances novel organ regeneration therapy for end-stage liver disease. LyGenesis, a … Continue reading "LyGenesis progresses Phase 2a clinical trial in...
